+検索条件
-Structure paper
| タイトル | Discovery and characterization of potent broadly neutralizing antibodies from human survivors of severe fever with thrombocytopenia syndrome. |
|---|---|
| ジャーナル・号・ページ | EBioMedicine, Vol. 111, Page 105481, Year 2025 |
| 掲載日 | 2024年12月6日 |
著者 | Shuo Zhang / Hang Shang / Shuo Han / Jiachen Li / Xuefang Peng / Yongxiang Wu / Xin Yang / Yu Leng / Fengze Wang / Ning Cui / Lingjie Xu / Hongkai Zhang / Yu Guo / Xiaoyu Xu / Nan Zhang / Wei Liu / Hao Li / ![]() |
| PubMed 要旨 | BACKGROUND: Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne phlebovirus that causes viral hemorrhagic fever. Pandemic concerns have arisen due to the increased ...BACKGROUND: Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne phlebovirus that causes viral hemorrhagic fever. Pandemic concerns have arisen due to the increased human-to-human transmission and high mortality rate, highlighting the urgent need for specific therapeutics. 手法: Our observational study characterized the memory B cell response to natural SFTSV infection in four survivors. Monoclonal antibodies (mAbs) targeting the SFTSV glycoprotein N (Gn) were isolated and tested for in vitro neutralizing activities and effects on virus binding. Structural analysis was performed to identify neutralizing epitopes recognized by the mAbs. Prophylactical and therapeutical protections were evaluated using a lethal SFTSV infection model. FINDINGS: The selected mAbs exhibiting neutralizing activity primarily originate from the IGHV5-51 and IGHV3-30 germlines and target four distinct antigenic sites on SFTSV Gn. These elite mAbs effectively blocked the interaction between Gn and the cell receptor, preventing infections from five phylogenetically distinct SFTSV clades. Structural analysis revealed a novel neutralizing epitope located within SFTSV Gn domain I recognized by the elite mAbs. In mice of lethal infections with different SFTSV strains, administering a low dose of elite mAbs significantly improved survival rates in both prophylactic and therapeutic settings. INTERPRETATION: This study identifies potent broadly neutralizing antibodies that holds promise for use in humans against SFTSV infection and highlights inhibition of receptor binding as a crucial mechanism for effective antibody-mediated neutralization against phleboviruses. FUNDING: The National Key Research and Development Plan of China (2018YFE0200401, 2022YFC2303300), National Natural Science Foundation of China (81825019), China Postdoctoral Science Foundation (2023M741824). |
リンク | EBioMedicine / PubMed:39644769 / PubMed Central |
| 手法 | EM (単粒子) |
| 解像度 | 2.37 - 2.77 Å |
| 構造データ | EMDB-60112, PDB-8zhq: ![]() EMDB-60113: SFTSV Gn in complex with JK-2/12 Fab |
| 化合物 | ![]() ChemComp-NAG: |
| 由来 |
|
キーワード | VIRAL PROTEIN / Complex / Neutralizing antibody / SFTSV |
ムービー
コントローラー
構造ビューア
万見文献について



著者
リンク



homo sapiens (ヒト)
severe fever with thrombocytopenia syndrome virus (ウイルス)
キーワード